» Articles » PMID: 9601079

BeWo Choriocarcinoma Cells Produce Laminin 10

Overview
Journal Biochem J
Specialty Biochemistry
Date 1998 Jun 26
PMID 9601079
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

BeWo is a choriocarcinoma cell line that generates an extracellular matrix (ECM) rich in laminin and is a useful model for human trophoblast. Immunofluorescence with monoclonal antibodies demonstrates that BeWo ECM contains laminin subunits beta1 and gamma1. Immunoprecipitation from conditioned medium shows that the cells secrete two distinct laminin trimers both containing beta1 and gamma1 but with alpha subunits of approx. 400 and 450 kDa. The culture medium also contains a species thought to be beta1 gamma1 dimer. Immunoprecipitation with monoclonal antibody 4C7, previously thought to recognize the alpha1 subunit, isolates complexes containing only the smaller alpha subunit. A second complex containing the larger alpha subunit along with beta1, gamma1 and a 150 kDa polypeptide is precipitated from 4C7-depleted medium with an anti-(laminin 1) polyclonal antibody. Peptide sequencing demonstrates that the 4C7-reactive species is alpha5, which is present as two similarly sized polypeptides. mRNA species encoding laminin subunits alpha1, alpha5, beta1, beta2 and gamma1 are all present in the cells. These results demonstrate the secretion of a novel laminin isoform, laminin 10, the subunit composition of which is alpha5 beta1 gamma1. Laminin 1 is also produced. No evidence for the secretion of beta2-containing laminin isoforms could be derived despite the presence of beta2 mRNA. Analysis with reverse transcriptase-mediated PCR also showed the presence of laminin alpha5 in first-trimester placenta and decidua.

Citing Articles

Detrimental effects of ethanol and its metabolite acetaldehyde, on first trimester human placental cell turnover and function.

Lui S, Jones R, Robinson N, Greenwood S, Aplin J, Tower C PLoS One. 2014; 9(2):e87328.

PMID: 24503565 PMC: 3913587. DOI: 10.1371/journal.pone.0087328.


A novel monoclonal antibody to human laminin α5 chain strongly inhibits integrin-mediated cell adhesion and migration on laminins 511 and 521.

Wondimu Z, Omrani S, Ishikawa T, Javed F, Oikawa Y, Virtanen I PLoS One. 2013; 8(1):e53648.

PMID: 23308268 PMC: 3538678. DOI: 10.1371/journal.pone.0053648.


Laminin-511: a multi-functional adhesion protein regulating cell migration, tumor invasion and metastasis.

Pouliot N, Kusuma N Cell Adh Migr. 2012; 7(1):142-9.

PMID: 23076212 PMC: 3544778. DOI: 10.4161/cam.22125.


Integrin alpha 7 interacts with high temperature requirement A2 (HtrA2) to induce prostate cancer cell death.

Zhu Z, Yu Y, Zheng Z, Song Y, Xiang G, Nelson J Am J Pathol. 2010; 177(3):1176-86.

PMID: 20651226 PMC: 2928952. DOI: 10.2353/ajpath.2010.091026.


Laminin deposition in the extracellular matrix: a complex picture emerges.

Hamill K, Kligys K, Hopkinson S, Jones J J Cell Sci. 2009; 122(Pt 24):4409-17.

PMID: 19955338 PMC: 2787456. DOI: 10.1242/jcs.041095.


References
1.
Burgeson R, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H . A new nomenclature for the laminins. Matrix Biol. 1994; 14(3):209-11. DOI: 10.1016/0945-053x(94)90184-8. View

2.
Wewer U, Gerecke D, Durkin M, Kurtz K, Mattei M, Champliaud M . Human beta 2 chain of laminin (formerly S chain): cDNA cloning, chromosomal localization, and expression in carcinomas. Genomics. 1994; 24(2):243-52. DOI: 10.1006/geno.1994.1612. View

3.
Iivanainen A, Sainio K, Sariola H, Tryggvason K . Primary structure and expression of a novel human laminin alpha 4 chain. FEBS Lett. 1995; 365(2-3):183-8. DOI: 10.1016/0014-5793(95)00462-i. View

4.
Sorokin L, Pausch F, Frieser M, Kroger S, Ohage E, Deutzmann R . Developmental regulation of the laminin alpha5 chain suggests a role in epithelial and endothelial cell maturation. Dev Biol. 1997; 189(2):285-300. DOI: 10.1006/dbio.1997.8668. View

5.
Miner J, Lewis R, Sanes J . Molecular cloning of a novel laminin chain, alpha 5, and widespread expression in adult mouse tissues. J Biol Chem. 1995; 270(48):28523-6. DOI: 10.1074/jbc.270.48.28523. View